| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11025371 | International Journal of Pediatric Otorhinolaryngology | 2018 | 7 Pages |
Abstract
As many as two out of a hundred children between the ages of 2-3 years were affected by significant middle ear disease i.e. CSOM or bilateral OME. These data could be useful as a baseline for estimating the impact of pneumococcal conjugate vaccines (PCV13) introduced in July 2011 for infants in Cameroon.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
John Njuma Libwea, Marie Kobela, Paul Koki Ndombo, Ritva K. Syrjänen, Heini Huhtala, Ninying Fointama, Sinata Koulla-Shiro, Hanna Nohynek, J. Pekka Nuorti, Arto A. Palmu,